Latest disclosed round
Series C
- Date
- 2026-01-01
- Amount
- USD 87m
- Sector
- Biotech & techbio
- Companies House
- 08663936
Later stage / growth
Nuclera
Synthetic biology / protein & antibody engineering hardware
CandidateSeries CCambridge
Evidence status
Review retained
- Identity
- Candidate
- Match
- High candidate
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
5 linked investors
Funding record
2 disclosed rounds
| Date | Stage | Amount | Investors |
|---|---|---|---|
| 2026-01-13 | Series C extension | $12M additional (Series C total $87M) | Elevage Medical Technologies, Jonathan Milner, British Patient Capital, GK Goh |
| 2024-10-16 | Series C | $75M | Elevage Medical Technologies, British Patient Capital, Cambridge Innovation Capital, GK Goh, M&G Catalyst, E Ink Holdings, Michael D. McCreary, Uni Power Group, Verve Ventures |
Traceability
Source trail
Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.